Dies ist eine Druckversion der Seite: "Company Profile"

Company profile

VPM is a private vaccine and biopharmaceutical development company with a high potential for value creation. The company was founded in August 2002 and is based in Hannover. Germany.

VPM´s product portfolio targets combined markets of over 6 billion € in cancer, multiple sclerosis and infectious diseases. Each product is developed together with partners with specific expertise in the respective field. VPM does not bind capital in own laboratories or plants, but focuses on efficient management of it´s projects. In general VPM holds worldwide exclusive licence for all of its product.

Together with it´s consortium partners VPM also offers services to third parties.

Mission

Vakzine Projekt Management GmbH (VPM)

acquires promising vaccine candidates

from academia, develops them

with a consortium of partners

and commercializes the results

Drucken - Fenster schließen Zurück zu Vakzine Projekt Managemt